Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 30 Sept 2026. Factsheet Jun 2026. About · Disclosures
HDFC Pharma and Healthcare Fund Regular Plan Growth
HDFC Mutual Fund₹21.181
As on 30 Sept 2026
Returns
From NAVs through 30 Sept 2026
Calendar years
Rolling 1-year · 24 overlapping windows
Fund facts
Fund details from the Jun 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
35 holdings · portfolio as on 30 May 2026
- 9.2%Sun Pharmaceuticals Industries LtdHealthcare
- 8.02%Divi's Laboratories LtdHealthcare
- 5.45%Lupin LtdHealthcare
- 5.26%Max Healthcare Institute Ltd Ordinary SharesHealthcare
- 5.18%Aster DM Healthcare Ltd Ordinary SharesHealthcare
- 4.92%Cipla LtdHealthcare
- 4.5%Acutaas Chemicals LtdBasic Materials
- 4.36%Alkem Laboratories LtdHealthcare
- 4.15%Anthem Biosciences LtdHealthcare
- 3.5%Ipca Laboratories LtdHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
Who manages this fund
2 fund managers
- NMNikhil Mathur2.5 years in the industryRuns 1 scheme
- DMDhruv Muchhal2.7 years in the industryRuns 46 schemes
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
FAQ
What is HDFC Pharma and Healthcare Fund Regular Plan Growth NAV today?
- The latest NAV of HDFC Pharma and Healthcare Fund Regular Plan Growth is ₹21.181 as on 30 Sept 2026.
How has HDFC Pharma and Healthcare Fund Regular Plan Growth performed vs its category?
- 1-year return +26.37%. Past performance does not guarantee future returns.
What are the returns of HDFC Pharma and Healthcare Fund Regular Plan Growth?
- Trailing returns from published NAVs: 1 year +26.37%, 3 year +28.69% a year, 5 year +28.69% a year, since our first NAV +28.69% a year. Past performance does not guarantee future returns.
How would a SIP in HDFC Pharma and Healthcare Fund Regular Plan Growth have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +28.69%. It is not a forecast.
What is the expense ratio and fund size of HDFC Pharma and Healthcare Fund Regular Plan Growth?
- For HDFC Pharma and Healthcare Fund Regular Plan Growth, the expense ratio is 1.97% and fund size (AUM) is ₹3,310.64 Cr.
What is the ISIN of HDFC Pharma and Healthcare Fund Regular Plan Growth?
- The ISIN for HDFC Pharma and Healthcare Fund Regular Plan Growth is INF179KC1HL7.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.